Pancreatic Cancer Research

ResearcherUniversity of Kansas Medical CenterNo recent work listed

Qi Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0001-8944-2109; OpenAlex author ID A5100340217. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper

Papers 3

  1. High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study. Last author DOI 10.1038/s41598-017-17568-8↗
  2. Mechanism of Ascorbate-Induced Cell Death in Human Pancreatic Cancer Cells: Role of Bcl-2, Beclin 1 and Autophagy. Co-author DOI 10.1055/s-0035-1546132↗
  3. Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Last author DOI 10.1016/j.freeradbiomed.2011.03.007↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kishore Polireddy · 2 shared papers, 2015–2017 · strength 0.12
  2. Mark Levine · 2 shared papers, 2011–2017 · strength 0.09
  3. Jeanne Drisko · 2 shared papers, 2011–2017 · strength 0.09
  4. Fang Fan · 1 shared paper, 2017 · strength 0.06
  5. Ping Chen · 1 shared paper, 2017 · strength 0.06
  6. Jun Yu · 1 shared paper, 2017 · strength 0.06
  7. Ruochen Dong · 1 shared paper, 2017 · strength 0.06
  8. Masayuki Fukui · 1 shared paper, 2015 · strength 0.06
  9. Bao Ting Zhu · 1 shared paper, 2015 · strength 0.06
  10. Michael Graham Espey · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.